Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
J. Fred Pritchard, Ph.D. Vice-President, Strategic Development, Celerion Inc.
Technologies that brings data to investigators almost as soon as it is collected is of high value...
Bhaskar Sambasivan, President, Patient Services & Chief Strategy Officer, & ,Herbert Lee, PharmD, Senior Vice President, Medical Information Services and Pharmacovigilance, EVERSANA
Eric Perakslis, SVP (Informatics), Takeda
Innovation is a truly curious beast and most organizations struggle righteously between...
Tim Jackson, VP (Information Technology), Advanced Clinical
How often are you asked to make decisions where there is a large chunk of “unknowns”?...
Michael F Murphy, MD, PHD, Chief Medical And Scientific Officer, Worldwide Clinical Trials
Research and development costs to market authorization are formidable. Given the pattern of...
Amanda Hayward, Managing Director, Venture Capital Investments, Connecticut Innovations
Enabling technology platforms such as CRISPR-C as gene editing, sequencing technology, big...
Andrew Garrett, PhD, Executive Vice President, Scientific Operations, ICON Clinical Research [NASDAQ: ICLR]
Increasingly, Biotech companies are taking drugs through to regulatory approval and...
Karen Matijak, VP-Strategic Initiative Delivery, NBTY
I believe the biggest challenge in tackling workflow is delivering a solution that is both...
Margo Weisz, Partner, City Lights Group
Nine years ago, Dr. Char Hu, a PhD in molecular physics, was doing research on Alzheimer’s...
Paul Strouts, Global MD (Life Sciences Division), Hays
Claims that automation is taking over the world of work feature heavily in the current...
